Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
UpToDate
NCCN COVID-19 Resources Page
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic